# Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

> **NCT05417841** · NA · COMPLETED · sponsor: **Beijing Hospital** · enrollment: 218 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Degludec and Insulin Aspart Injection
- **DRUG:** Insulin Aspart Injection

## Key facts

- **NCT ID:** NCT05417841
- **Lead sponsor:** Beijing Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-23
- **Primary completion:** 2025-08-15
- **Final completion:** 2025-08-15
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05417841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05417841, "Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM". Retrieved via AI Analytics 2026-05-19 from https://api.ai-analytics.org/clinical/NCT05417841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*